# Denali Therapeutics Inc.: Form 8-K, filed Mar 16, 2022

- Company: [Denali Therapeutics Inc.](/companies/dnli.md) (CIK 1714899)
- Form: 8-K
- Filed: 2022-03-16
- Accepted by EDGAR: Mar 16, 2022, 16:20 ET
- Period: 2022-03-14
- Accession: 0001193125-22-077264
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1714899/000119312522077264/d310285d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1714899/000119312522077264/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1714899/000119312522077264/d310285d8k.htm

Filed Mar 16, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-077264. Last ingested by Listed: Nov 3, 2026, 19:01 ET. No prices; not investment advice.
